← back to scans
When will JUUL release Mango to the public?
5%
Agent
10%
Market Price
-5.2%
Edge
76%
Confidence
29,586
Volume
5.0c
Spread
90
Days to resolution
6
Markets in event
final rationale
Mean of 5 draws (0.05, 0.05, 0.04, 0.04, 0.06). (0) Resolution check: nothing shows the condition met. The FDA authorized-products list (checked Oct 1, 2026) shows JUUL holds only tobacco and menthol authorizations, including JUUL2 and Polar Menthol. JUUL's newsroom has no Mango announcement, and the resolution-source fetch was only a login page. (a) About 3 months remain until Jan 1, 2027. (b) Status quo is No. JUUL has not even filed a Mango PMTA; its Aug 28 statement only says it plans flavor filings. Its past authorizations took 3-5 years, and the May 2026 enforcement-discretion guidance appears to exclude flavored e-vapor products. (c) NO scenario: JUUL files flavor PMTAs sometime in 2026-27, the FDA reviews them for a year or more, and nothing reaches the public before the deadline. (d) YES scenario: JUUL quickly files a Mango PMTA for the age-gated JUUL2, citing the Glas mango precedent, and either gets unusually fast authorization or launches under enforcement discretion. Alternatively, a JUUL Mango release abroad counts; JUUL2 Mango already sells in the UK. But the market staying unresolved after the October 2025 UK launch implies a US release is required. Anchor: Kalshi is at 10% (bid 9 / ask 14), and the recent uptick seems speculative rather than news-driven. Polymarket's 44% comes from a near-zero-volume market ($187) and carries little weight. Given no filing and the short window, I shade below the Kalshi mid to about 5%, keeping some mass on wording ambiguity and surprise regulatory action.
price vs. prediction
market price
agent forecast at t+0
16 follow-ups
1. Planner Opus 5.5 · picks the research tools
Tools chosen:
kalshi_direct
kalshi_related
resolution_source
article_search
polymarket_related
wikipedia
Planner reasoning
The Kalshi price is the anchor for this market. Sibling flavor markets in the KXJUULFLAVOR series show how the crowd prices other JUUL flavor launches. Flavored ENDS releases depend on FDA marketing orders (PMTA), so one targeted search for FDA authorization of JUUL flavored products adds a fact the general loops might miss. Wikipedia covers the regulatory background.
2. Research parallel tool calls + 4 web research loops (Sonnet 5) · read raw by the forecasters
at a glance
RESEARCH DIGEST (built in code: tool summaries and each report's bottom line; the forecasters read the full tool outputs and reports)
Tools
- kalshi_direct: ## This Market's Kalshi Data **Mango** (KXJUULFLAVOR-27-MAN) - Current price (probability): 10.00% (live; bid 9% / ask 14%) - 7-day price change: +5.00% - 30-day price change: +8.00% - Average daily volume: 55 contracts - Price range: 2.00% - 75.00% - Data points: 34 days
- resolution_source: already_resolved=unclear; matches_criteria=False; last_updated=unknown. The fetched page is JUUL's generic login/homepage with no mention of a Mango flavor release or any flavor announcement.
- kalshi_related: 0 related markets / summaries. series KXJUULFLAVOR: 0 markets (skipped 6 no-signal) | keyword 'JUUL flavor': no matches
- article_search: Fetched 9 unique articles across 2 queries (lookback=120d). 'FDA marketing order JUUL flavored pods mango 2026': 10 articles | 'JUUL PMTA flavored products authorization': 10 articles
- polymarket_related: Polymarket search over 1 keyword(s), kept 5 matches. keyword 'JUUL': 5 markets
- wikipedia: Fetched 1 Wikipedia entries (0 missing pages).
Research loops, bottom lines
- current state: As of today JUUL has never had a Mango flavor authorized or even formally filed for FDA review in the current regulatory cycle; it has only secured tobacco and menthol authorizations (July 2025 original system, August 2026 JUUL2), has merely stated an intent to pursue "flavors beyond tobacco and menthol" with no filing timeline disclosed, and the only FDA-authorized mango vape product in the US (Glas's Gold pod) belongs to a rival embroiled in patent litigation with JUUL — making a public JUUL M
- base rate: Historically, JUUL flavor-authorization events (full device approval, flavor-ban reversals) have taken multi-year regulatory cycles and even JUUL's biggest recent win (July 2025 MGO) excluded fruit flavors; the only mango authorization to date in this product category went to a competitor (Glas) on a different, age-gated device, not to JUUL. Base rates and secondary prediction-market/model estimates (Mango ~5% market / ~1-2% model as of mid-2026, trending down after an initial speculative spike)
- yes case: The single most plausible YES path is JUUL leveraging its already-authorized, age-gated JUUL2 hardware and its existing UK Mango formulation to file a Mango PMTA that either (a) wins fast-tracked authorization on the Glas precedent, or (b) is merely "accepted for substantive review," letting JUUL sell Mango under the FDA's May 2026 enforcement-discretion guidance without waiting for a final MGO — but as of October 2, 2026 no such PMTA has been confirmed filed, so this path requires multiple stil
- no case: JUUL has not filed, let alone received authorization for, a Mango PMTA; its own August 28, 2026 statement describes only an intent to submit future flavor filings with no named flavor or timeline; its historical authorization cycles run 3-5 years; its regulatory/legal bandwidth is consumed by multiple active patent fights (AJ Marketing, NJOY/Altria, Glas) running into 2027; and FDA's own flavor-enforcement guidance explicitly excludes flavored products from leniency — all of which argue status-q
tools
| tool | status | time | items | summary |
|---|---|---|---|---|
| kalshi_direct | OK | 0.2s | 1 | ## This Market's Kalshi Data **Mango** (KXJUULFLAVOR-27-MAN) - Current price (probability): 10.00% (live; bid 9% / ask 14%) - 7-day price change: +5.00% - 30-day price change: +8.00% - Average daily volume: 55 contracts - Price range: 2.00% - 75.00% - Data points: 34 days |
| kalshi_related | OK | 0.5s | 0 | 0 related markets / summaries. series KXJUULFLAVOR: 0 markets (skipped 6 no-signal) | keyword 'JUUL flavor': no matches |
| resolution_source | OK | 2.6s | 1 | already_resolved=unclear; matches_criteria=False; last_updated=unknown. The fetched page is JUUL's generic login/homepage with no mention of a Mango flavor release or any flavor announcement. |
| article_search | OK | 0.6s | 9 | Fetched 9 unique articles across 2 queries (lookback=120d). 'FDA marketing order JUUL flavored pods mango 2026': 10 articles | 'JUUL PMTA flavored products authorization': 10 articles |
| polymarket_related | OK | 0.5s | 5 | Polymarket search over 1 keyword(s), kept 5 matches. keyword 'JUUL': 5 markets |
| wikipedia | OK | 0.3s | 1 | Fetched 1 Wikipedia entries (0 missing pages). |
research loops
·
4/4 ok ·
14 searches ·
6 page reads
| dimension | status | time | searches | page reads | report |
|---|---|---|---|---|---|
| current state | OK | 31s | 4 | 2 | 5461 chars |
| base rate | OK | 29s | 2 | 2 | 5544 chars |
| yes case | OK | 38s | 5 | 1 | 5133 chars |
| no case | OK | 33s | 3 | 1 | 6123 chars |
report: current state
- [2025-07-18] JUUL Labs received its first FDA marketing granted orders (MGOs) for the original JUUL System, but only in
Virginia Tobacco and Menthol flavors—both in 3 and 5 percent nicotine strengths
; no fruit flavor was included. (juullabs.com)
- [2025-07-18] In its own statement, JUUL said it was looking ahead, noting it had
developed a portfolio of adult-oriented flavors beyond Virginia Tobacco and Menthol and the CEO said the company hopes to win authorization for its next-generation device and is also considering applying to FDA for more flavors
, but no PMTA for Mango was confirmed as filed. (juullabs.com, wusf.org)
- [2026-05-05] FDA made its first-ever fruit-flavor authorization, but to a competitor, not JUUL:
the FDA authorized the marketing of 4 Glas electronic nicotine delivery systems through the PMTA pathway... marketed under the names Classic Menthol, Fresh Menthol, Gold, and Sapphire. Gold and Sapphire correspond to mango and blueberry flavors, respectively
. No JUUL-branded mango product was part of this authorization. (pharmacytimes.com)
- [2026-05-11] JUUL responded to the FDA's broader flavor policy shift:
On May 11, 2026, Juul Labs filed a comment in response to FDA's March 2026 Draft Guidance on Applications for Flavored E-Cigarettes
, indicating engagement with a potential path for future flavor applications, but not a submitted Mango PMTA. (juullabs.com)
- [2026-06] Commentary noted the FDA's evolving stance:
FDA Defends Approval of Fruit-Flavored Vapes Despite Limited Smoking-Cessation Advantage... the evidence showed that the authorized products could provide a meaningful benefit to adult smokers when evaluated as part of the broader tobacco harm reduction landscape
, suggesting a somewhat more permissive regulatory posture going forward, though still untested for JUUL-branded mango. (tobaccoinsider.com)
- [2026-08-27/28] FDA authorized JUUL's next-generation JUUL2 System, but again flavor-limited:
The authorized products are part of the JUUL2 e-cigarette system made by JUUL Labs and include a tobacco-flavored pod, a menthol-flavored pod, and the JUUL2 device
— no mango or other fruit flavor. (fda.gov)
- [2026-08-28] JUUL explicitly signaled future flavor ambitions without a firm date:
"We will build on the JUUL2 platform with a robust series of FDA filings, including 5% nicotine concentration products and a portfolio of flavors — beyond tobacco and menthol — that are targeted to adult nicotine consumers."... Juul Labs says it plans PMTAs for 5% JUUL2 products and flavors beyond tobacco and menthol
, meaning any Mango flavor would require a new PMTA filing and subsequent FDA review — a process that took roughly 5-14 months for JUUL's prior authorizations. (nicotineinsider.com)
- [2026-09 (ongoing)] A patent dispute between JUUL and its competitor is actually delaying the only authorized "mango" vape product on the market:
the FDA has granted marketing authorization to only two (2) non-tobacco, non-menthol "fruit flavored" ENDS products (blueberry and mango flavored pods made by Glas Vapor). Due to a patent dispute, Glas' newly authorized "fruit flavored" products are unlikely to go on the market any time soon. Juul Labs filed a patent infringement lawsuit against Glas, Inc.
This underscores JUUL's own mango remains unavailable, and even rival mango pods are stalled in litigation. (SEC 10-Q, Charlie's Holdings)
- [2026-09-01] The comprehensive FDA-authorized vape product tracker confirms current status:
As of September 1, 2026, 48 ENDS products hold an FDA marketing granted order... They come from five companies: R.J. Reynolds (Vuse), NJOY, Logic, JUUL Labs and Glas
; JUUL's authorized flavors remain limited to Virginia Tobacco and Menthol across both JUUL and JUUL2 systems, with Mango not among them. (vapetrends360.com)
- [2026-09-15 (approx.)] A consumer-facing review summarized current retail reality:
Four JUULpod flavors are authorized for sale in the United States: Virginia Tobacco and Menthol, each in 3% and 5% nicotine. Mango, mint, cucumber, crème brûlée and fruit were pulled in 2019 and none of them came back
, and clarified that the only FDA-authorized "mango" product in the US is Glas's Gold pod, not a JUUL product. (vapecityusa.com)
- [2026-10-02] No JUUL newsroom post, FDA announcement, or press release as of today reports a Mango flavor PMTA submission, review, or authorization for JUUL/JUUL2; the most recent JUUL newsroom entry remains the August 28, 2026 JUUL2 authorization statement. (juullabs.com/about/newsroom)
BOTTOM LINE: As of today JUUL has never had a Mango flavor authorized or even formally filed for FDA review in the current regulatory cycle; it has only secured tobacco and menthol authorizations (July 2025 original system, August 2026 JUUL2), has merely stated an intent to pursue "flavors beyond tobacco and menthol" with no filing timeline disclosed, and the only FDA-authorized mango vape product in the US (Glas's Gold pod) belongs to a rival embroiled in patent litigation with JUUL — making a public JUUL Mango release before January 1, 2027 look unlikely based on the current regulatory pipeline.
NOT FOUND: No evidence of a JUUL PMTA submission specifically for a Mango-flavored pod; no FDA docket or review timeline for any JUUL fruit-flavor application; no JUUL press release or FDA notice dated within the last 30 days (September 2026) announcing new flavor filings or authorizations.
report: base rate
- [2019] [2020]
In November 2019 JUUL announced it would stop selling mint-flavored pods in the US, and in January 2020 the FDA finalized a policy restricting unauthorized flavored cartridge-based e-cigarettes except tobacco and menthol, effectively banning mango nationwide.
This six-year-plus absence is the key historical base for extrapolating "will it return." Source: https://wellyhub.com/understanding-why-you-cant-find-them-is-juul-selling-mango-again
- [2022-2024] JUUL's regulatory track record shows FDA process moves very slowly and often reverses:
the FDA issued a marketing denial order to Juul in June 2022, Juul got a court stay, the FDA reversed course weeks later, and in 2024 the agency rescinded its denial and put the applications back into scientific review.
Source: https://vaping360.com/vape-news/8429/fda-authorizes-juul-device-and-pods/
- [2025-07-17] After roughly five years,
the FDA issued marketing granted orders for the JUUL System, built on over 110 scientific studies Juul submitted as part of its 2020 applications.
But authorization was limited to tobacco and menthol only, not fruit flavors — showing that even a "win" for JUUL historically excludes flavors like mango. Source: https://www.juullabs.com/juul-labs-statement-on-fda-marketing-authorizations/
- [2026-05-05] For the first time in FDA history, a non-JUUL company broke the fruit-flavor barrier:
the FDA authorized the sale of fruit-flavored vape products from Los Angeles-based Glas Inc., including mango and blueberry-flavored pods dubbed Gold and Sapphire.
This is the first precedent of any mango e-cigarette flavor being authorized in the modern PMTA era — but it did not apply to JUUL. Source: https://fortune.com/2026/05/07/fda-authorizes-fruit-flavored-vapes-mango-blueberry-trump-administration-american-politics-tobacco-companies/
- [2026-09-14] Analysis of the Glas precedent concludes JUUL mango specifically remains unauthorized:
on May 5, 2026 the FDA authorized its first non-tobacco, non-menthol pods, including a mango, but they're not JUULpods — what unlocked that wasn't a softer view on flavor, it was age verification built into the device.
Source: https://vapecityusa.com/blog/post/juul-flavors-2026-legal
- [2026-08-28]
The FDA has authorized 48 e-cigarette products, including devices, from just five manufacturers as of Aug. 28,
and
several of JUUL's flavors popular among underage users, including mango, mint and creme, remain discontinued even as the FDA approved sales of the first fruit-flavored e-cigarettes from a different company in May.
Source: https://www.11alive.com/article/news/nation-world/juul-vaping-ecigarette-nicotine-fda-authorization-new-products-device-menthol-pods/507-b3a206f7-a12e-4547-aad7-995400716858
- [2026-06-05] Sibling/related prediction markets show persistently low odds for a JUUL Mango relaunch: an aggregator's model-based forecast cross-referencing Kalshi pricing shows
the probability of a "Mango" flavor relaunch falling from a starting point of 43.0% to a current low of 5.0%, with the most dramatic price action occurring in mid-May 2026, a rapid spike and subsequent collapse.
Source: https://octagonai.co/markets/financials/product-launches/what-flavors-will-juul-relaunch/
- [2026-06-05] The same tracker's independent quantitative model puts Mango even lower than market pricing:
as of May 2026, no approved application exists for a JUUL flavor relaunch, and market odds for Mango sat around 5.0% while the model put it at 1.4%, versus Mint at 25.0% market / 13.7% model.
Source: https://octagonai.co/markets/financials/product-launches/what-flavors-will-juul-relaunch/
- [2025-10/2026-01] JUUL's international (UK) business shows mango is commercially viable and already relaunched abroad, but not in the US: the JUUL2 device's UK flavor lineup expanded with Mango, Watermelon, Apple and Lychee in October 2025 and Peach in January 2026, per the Octagon summary citing Nicotine Insider — indicating corporate appetite to sell mango exists, but only outside the stricter US regulatory regime. Source: https://octagonai.co/markets/financials/product-launches/what-flavors-will-juul-relaunch/
- [2026-sep] Consumer/industry trade commentary treats a JUUL-branded mango return as effectively foreclosed under current rules:
Mango JUULpods were withdrawn in 2019 and have never been authorized since; the FDA did authorize a mango-flavored pod in May 2026, but it's made by Glas and runs on a different device with built-in age verification.
Source: https://vapecityusa.com/blog/post/juul-flavors-2026-legal
BOTTOM LINE: Historically, JUUL flavor-authorization events (full device approval, flavor-ban reversals) have taken multi-year regulatory cycles and even JUUL's biggest recent win (July 2025 MGO) excluded fruit flavors; the only mango authorization to date in this product category went to a competitor (Glas) on a different, age-gated device, not to JUUL. Base rates and secondary prediction-market/model estimates (Mango ~5% market / ~1-2% model as of mid-2026, trending down after an initial speculative spike) imply a low prior for JUUL mango reaching the US public before 2027.
NOT FOUND: No evidence that JUUL Labs has filed a PMTA/application specifically for a US mango flavor as of the latest sources (September 2026); no official JUUL statement announcing mango relaunch plans in the US; could not access live Kalshi/Polymarket pricing (excluded per instructions) beyond third-party snapshots that are themselves dated June 2026.
report: yes case
YES means: JUUL Labs makes a Mango-flavored product commercially available for purchase by the general public in the United States at any point before January 1, 2027 (either via a formal FDA marketing authorization or via a product actually reaching consumers, per the market's literal "releases... to the public" wording).
- [2026-05-05] The FDA's first-ever authorization of a non-tobacco/non-menthol flavor went to a rival (Glas's "Gold" pod), but the mechanism that unlocked it—an age-gated, smartphone-verified device—is structurally identical to JUUL's own approach:
the FDA authorized marketing of 4 Glas electronic nicotine delivery systems through the PMTA pathway, the agency announced on May 5, 2026, marking the first time it has authorized nontobacco, nonmenthol flavored vaping products for sale in the US
, establishing a live regulatory precedent JUUL can now point to.
- [2026-08-28] JUUL's own next-generation device, JUUL2, already clears the hardware bar: it is
a new device with built-in age-verification technology, called the JUUL2... This device has been granted an MGO, and undoubtedly signals JUUL Labs' intention to launch non-tobacco, non-menthol flavors in the near future
— removing the main technical objection (youth access) that previously blocked fruit flavors.
- [2026-08-28] JUUL has publicly committed, in its own authorization statement, to file for Mango-type flavors:
"We have a robust series of filings planned, including submissions for 5% nicotine concentration products and a portfolio of flavors, beyond tobacco and menthol, that are targeted to adult consumers."
- [2026-08-28] Vaping360 reports the groundwork is already laid, not merely promised:
in its Aug. 28 statement, the company said it submitted the JUUL2 PMTAs in 2023 and plans additional applications for 5 percent nicotine products and flavors beyond tobacco and menthol
, meaning flavor PMTAs could follow the same multi-year-old dossier rather than starting from zero.
- [2026-05 (reported)] Political tailwinds exist: Fortune reported that Trump administration pressure preceded the Glas mango authorization, per the Octagon tracker's citation of reporting titled
"the May 5, 2026, news that the FDA authorized fruit-flavored e-cigarettes, specifically mango and blueberry, for a competitor, Glas"
— the same administration remains in office through the market window, sustaining a favorable posture toward flavored vapes generally.
- [2026-05 (FDA guidance)] A second, faster pathway to literal "release" exists independent of a final MGO: Altria's 10-Q describes FDA's May 2026 enforcement-discretion guidance, under which
the FDA generally will not prioritize enforcement against e-vapor and oral nicotine pouch products with pending PMTAs that are undergoing scientific review
— if JUUL files and gets a Mango PMTA accepted into substantive review, it could plausibly sell Mango pods without triggering enforcement, which the Octagon analysis explicitly flags as
a "loophole" [that] could potentially allow JUUL to reintroduce certain flavors, such as Mint or Mango, while their PMTAs are still pending final approval
.
- [2026-01-04 (reported)] JUUL already manufactures and sells Mango commercially under its JUUL2 platform abroad, showing supply-chain and product readiness: the Octagon report cites that
JUUL's international flavors expansion included Mango, Watermelon, Apple, Lychee
in the UK, meaning a US Mango SKU is not a hypothetical product but an existing one that could be ported over quickly once any US regulatory gate opens.
- [2026-09-xx] Even JUUL's litigation posture cuts both ways: JUUL's own patent suit against Glas over the mango-pod hardware (noted in the Charlie's Holdings 10-Q) signals JUUL views the mango-capable device category as commercially important enough to fight over, consistent with intent to compete in that flavor segment itself rather than cede it.
- [2026-06 (model/market)] Independent quantitative modeling still assigns Mango a nonzero, trackable probability rather than treating it as impossible: Octagon's own model placed the Mango relaunch probability at a low but positive **2.4%** as of its June 5, 2026 update, reflecting that informed modelers see some realistic (if small) path to a pre-2027 release rather than dismissing it outright.
BOTTOM LINE: The single most plausible YES path is JUUL leveraging its already-authorized, age-gated JUUL2 hardware and its existing UK Mango formulation to file a Mango PMTA that either (a) wins fast-tracked authorization on the Glas precedent, or (b) is merely "accepted for substantive review," letting JUUL sell Mango under the FDA's May 2026 enforcement-discretion guidance without waiting for a final MGO — but as of October 2, 2026 no such PMTA has been confirmed filed, so this path requires multiple still-unconfirmed steps to occur within under three months.
NOT FOUND: No confirmed JUUL Mango PMTA submission date, no FDA docket number for a pending JUUL fruit-flavor application, and no explicit JUUL statement invoking the enforcement-discretion guidance as a basis for an interim Mango launch.
report: no case
YES means: JUUL Labs publicly releases (makes commercially available to consumers in the US) a Mango-flavored product before January 1, 2027, triggering the Kalshi "Mango" market to resolve Yes.
- [2026-08-28] JUUL's own newsroom statement announcing JUUL2 authorization says only:
"We have a robust series of filings planned, including submissions for 5% nicotine concentration products and a portfolio of flavors, beyond tobacco and menthol, that are targeted to adult consumers."
This is a plan to *submit* filings, not a filed PMTA — meaning Mango has not even entered the review queue as of the authorization date, let alone been authorized. (juullabs.com)
- [2026-10-01] The FDA's live authorized-products list, checked October 1, 2026, confirms JUUL's only 8 authorized entries remain
"JUULpods (Menthol 3.0%), JUULpods (Menthol 5.0%), JUULpods (Virginia Tobacco 3.0%), JUULpods (Virginia Tobacco 5.0%), JUUL Device, JUUL2 Device, JUUL2 Virginia Tobacco 2-pack 18 mg/mL nicotine, Polar Menthol JUUL2 pod"
— a second menthol variant was just added, not a fruit flavor, showing JUUL's incremental authorization pattern continues to prioritize tobacco/menthol line extensions over new flavor categories. (rxvape.com)
- [2026-09-03/09-10] Just days after the JUUL2 authorization, a new, unrelated patent suit hit JUUL:
"AJ Marketing LLC filed a patent infringement lawsuit against JUUL Labs on September 3, 2026, alleging that the JUUL 1 and... JUUL2 e-cigarette products infringe"
a 2010-filed patent — adding fresh legal/operational distraction to JUUL's US business precisely when it says it wants to pursue new flavor PMTAs. (zumovape.com)
- [2026-09 (filing date 2025-09)] JUUL's PMTA bandwidth is further strained by the NJOY/Altria ITC fight:
"NJOY, ALCS, and AGDC filed an action against JUUL with the ITC alleging patent infringement... A hearing before the ALJ is scheduled for September 2026, and we expect an initial determination from the ALJ in December 2026... the ITC's final determination in April 2027"
— litigation stretching well past the market's January 1, 2027 deadline, consuming JUUL regulatory/legal resources.
- [2025-09-30, ongoing] JUUL's fight against the only authorized US "mango" product (Glas's Gold pod) is itself unresolved and won't likely conclude before the deadline:
"the Commission has instituted a Section 337 investigation following a complaint filed by Juul Labs and VMR Products. The complaint, originally filed on Sept. 30, 2025, and supplemented in November and December... named respondents are Glas, Inc., and Glas, LLC... Juul and VMR... are seeking a limited exclusion order barring the importation of the accused products"
— showing JUUL's energy here is aimed at blocking a rival's mango pod, not launching its own.
- [2026-05] Even the FDA's own May 2026 enforcement-discretion guidance, which some read as flavor-friendly, explicitly carves out flavored products from its leniency:
"In May 2026, the FDA issued guidance concerning how it intends to enforce premarket review requirements for certain e-vapor and oral nicotine pouch products with pending PMTAs. The guidance indicates that the FDA generally will not prioritize enforcement against e-vapor and oral nicotine pouch products with (i) pending PMTAs that are undergoing scientific review, or (ii) pending Supplemental PMTAs for products, other than flavored e-vapor products, that have been accepted and pending for more than 180 days"
— flavored products are the one category explicitly excluded from this discretion, meaning even a filed Mango PMTA could face active enforcement risk rather than a fast lane.
- [2026-mid] A trade-press review of PMTA history notes FDA's own unpredictability on timing:
"FDA review timeframes have varied... It is therefore difficult to predict the duration of FDA reviews of SE reports or PMTAs"
— Altria's own 10-Q concedes the agency itself cannot be relied upon for any specific authorization date, undercutting any assumption that a hypothetical Mango filing could clear review before year-end 2026.
- [2026-mid] Historical precedent shows JUUL's fastest full-cycle authorization (original tobacco/menthol system) took from a 2020 filing to July 2025 grant — roughly five years — and the JUUL2 device took from a July 2023 PMTA filing to August 2026 authorization, roughly three years; no JUUL product has ever moved from filing to grant in under a year, making a hypothetical Mango filing-to-launch cycle within the ~15 months left on this contract (and with no filing yet even announced) inconsistent with JUUL's own track record. (tobaccoinsider.com)
- [2026-09] JUUL's zero flavor progress is reinforced by the fact that the one fruit-flavor win in the entire US market (Glas's Gold/mango pod) remains unsold at retail:
"the FDA has granted marketing authorization to only two (2) non-tobacco, non-menthol 'fruit flavored' ENDS products (blueberry and mango flavored pods made by Glas Vapor). Due to a patent dispute, Glas' newly authorized 'fruit flavored' products are unlikely to go on the market any time soon"
— if even an *already-authorized* mango product can't reach shelves due to litigation, a *not-yet-filed* JUUL mango product has a materially harder, longer path.
BOTTOM LINE: JUUL has not filed, let alone received authorization for, a Mango PMTA; its own August 28, 2026 statement describes only an intent to submit future flavor filings with no named flavor or timeline; its historical authorization cycles run 3-5 years; its regulatory/legal bandwidth is consumed by multiple active patent fights (AJ Marketing, NJOY/Altria, Glas) running into 2027; and FDA's own flavor-enforcement guidance explicitly excludes flavored products from leniency — all of which argue status-quo inertia and point to NO before January 1, 2027.
NOT FOUND: No JUUL PMTA docket number or FDA acceptance letter for any Mango-flavored product; no announced submission date for JUUL's promised "portfolio of flavors beyond tobacco and menthol"; no FDA public statement estimating a review timeline for any future JUUL fruit-flavor application.
3. Forecasters 5 draws · Opus 5.5 + GPT-5.6 Sol · plain mean
claude-opus-5-5
72% conf
| Yes | 5% |
| No | 95% |
(0) Resolution check: nothing shows the condition met. The FDA authorized-products list (checked Oct 1, 2026) shows JUUL holds only tobacco and menthol authorizations, including JUUL2 and Polar Menthol. JUUL's newsroom has no Mango announcement, and the resolution-source fetch was only a login page. (a) About 3 months remain until Jan 1, 2027. (b) Status quo is No. JUUL has not even filed a Mango PMTA; its Aug 28 statement only says it plans flavor filings. Its past authorizations took 3-5 years, and the May 2026 enforcement-discretion guidance appears to exclude flavored e-vapor products. (c) NO scenario: JUUL files flavor PMTAs sometime in 2026-27, the FDA reviews them for a year or more, and nothing reaches the public before the deadline. (d) YES scenario: JUUL quickly files a Mango PMTA for the age-gated JUUL2, citing the Glas mango precedent, and either gets unusually fast authorization or launches under enforcement discretion. Alternatively, a JUUL Mango release abroad counts; JUUL2 Mango already sells in the UK. But the market staying unresolved after the October 2025 UK launch implies a US release is required. Anchor: Kalshi is at 10% (bid 9 / ask 14), and the recent uptick seems speculative rather than news-driven. Polymarket's 44% comes from a near-zero-volume market ($187) and carries little weight. Given no filing and the short window, I shade below the Kalshi mid to about 5%, keeping some mass on wording ambiguity and surprise regulatory action.
claude-opus-5-5
72% conf
| Yes | 5% |
| No | 95% |
(0) Resolution check: nothing shows the condition met. FDA's authorized list, checked Oct 1, 2026, shows only Virginia Tobacco and Menthol JUUL/JUUL2 products. JUUL's newsroom has no Mango filing or launch. Its Aug 28 statement only says it plans future filings for flavors beyond tobacco and menthol. (a) About three months remain before the Jan 1, 2027 deadline. (b) Status quo is No: no Mango PMTA has been filed, and JUUL's past authorizations took 3-5 years from filing. The May 2026 enforcement-discretion guidance appears to exclude flavored products, so there is no quick launch-while-pending loophole. (c) NO scenario: JUUL files flavor PMTAs in late 2026 or 2027, and review runs well past the deadline amid its patent fights with Glas, NJOY/Altria and AJ Marketing. (d) YES scenario: JUUL files Mango for JUUL2 using the Glas age-verification precedent, and the FDA fast-tracks it under a flavor-friendly administration, or JUUL launches under some enforcement leniency. Either requires several unconfirmed steps within weeks. JUUL's UK Mango (launched Oct 2025) evidently does not count, or the market would already have resolved. The Kalshi anchor is 10% (bid 9 / ask 14), up recently, but I can find no news behind the rise. The 44% Polymarket price for the same question rests on about $187 of volume, so I give it little weight. I shade below Kalshi to about 5%, keeping some weight on a surprise filing or launch, or a lenient reading of the resolution.
claude-opus-5-5
74% conf
| Yes | 4% |
| No | 96% |
(0) Resolution check: nothing shows the condition met. JUUL's only FDA-authorized US products are tobacco and menthol pods for JUUL and JUUL2, per the FDA list checked 2026-10-01 and the 9/1 tracker. The resolution-source page has no Mango announcement, and no JUUL Mango PMTA has been confirmed filed. (a) Under three months remain before Jan 1, 2027. (b) Status quo is No: JUUL's 8/28 statement only says flavor filings are 'planned', with no flavor named and no timeline. (c) NO scenario: JUUL files flavor PMTAs sometime in 2027, or files late 2026. Either way, review takes years; JUUL2 took about 3 years and the original system about 5. FDA's May 2026 enforcement-discretion guidance explicitly excludes flavored e-vapor, so an interim launch while the PMTA is pending is risky. (d) YES scenario: JUUL quickly files a Mango PMTA for the age-gated JUUL2, citing the Glas mango precedent. Under a flavor-friendly administration, FDA either fast-tracks it or tolerates sales during review, and JUUL ports its existing UK Mango SKU before year-end. That requires several unprecedented steps in under 90 days. The UK Mango launch in Oct 2025 evidently did not trigger resolution, so the market is US-focused. Kalshi trades at 10% (bid 9/ask 14), up recently, likely on JUUL2 authorization speculation. The Polymarket 44% has only about $187 in volume and carries little weight. Given no filing and the known review timelines, I shade below the Kalshi anchor to about 4%, keeping some weight on resolution ambiguity and surprise FDA action.
gpt-5.6-sol
82% conf
| Yes | 4% |
| No | 96% |
(0) The condition is not already met: JUUL’s website shows no Mango announcement, and FDA/product tracking through October 1 shows JUUL authorized only for tobacco and menthol products, with no confirmed Mango PMTA filing. (a) About 91 days remain until the January 1, 2027 deadline, far shorter than JUUL’s historical three-to-five-year authorization cycles. (b) If nothing changes, Mango remains unavailable and the market resolves No. (c) The straightforward No scenario is that JUUL merely continues planning future flavor filings, without filing, obtaining authorization, and launching Mango before year-end. (d) A Yes scenario would require an unexpectedly rapid filing and launch using the age-verified JUUL2 platform and the favorable Glas fruit-flavor precedent, but the reported enforcement discretion does not clearly protect flavored e-vapor products. Kalshi’s 10% Yes price is the primary anchor; I move below it because no filing is documented with only three months left, while the nominally identical Polymarket price of 44% receives little weight because its reported volume is extremely small and conflicts sharply with the regulatory evidence.
gpt-5.6-sol
82% conf
| Yes | 6% |
| No | 94% |
(0) The condition is not already met: JUUL’s site shows no Mango announcement, and FDA/JUUL records through October 2026 show only tobacco and menthol authorizations, with no confirmed Mango PMTA filing. (a) About 91 days remain until the January 1, 2027 deadline. (b) If nothing changes, Mango remains unavailable and the market resolves No. (c) The likely No scenario is simple regulatory inertia: JUUL does not file for Mango promptly, or any filing remains under review given its prior three-to-five-year authorization cycles. (d) A Yes scenario would require JUUL to rapidly file for its existing overseas Mango formulation and then obtain unusually fast authorization or otherwise make it publicly available despite enforcement risk. Kalshi’s 10% Yes price is the primary anchor, while Polymarket’s 44% quote provides a contrary crowd signal but has very low volume and conflicts sharply with the documented regulatory pipeline. I move below Kalshi to 6% because, with less than three months left, there is still no named Mango application, FDA docket, acceptance letter, or flavor-specific launch timetable, although JUUL2’s age verification and the Glas mango precedent preserve a small path to Yes.
4. Final plain mean of 5 draws
5%
(76% confidence)
Yes: 5%
No: 95%
Mean of 5 draws (0.05, 0.05, 0.04, 0.04, 0.06). (0) Resolution check: nothing shows the condition met. The FDA authorized-products list (checked Oct 1, 2026) shows JUUL holds only tobacco and menthol authorizations, including JUUL2 and Polar Menthol. JUUL's newsroom has no Mango announcement, and the resolution-source fetch was only a login page. (a) About 3 months remain until Jan 1, 2027. (b) Status quo is No. JUUL has not even filed a Mango PMTA; its Aug 28 statement only says it plans flavor filings. Its past authorizations took 3-5 years, and the May 2026 enforcement-discretion guidance appears to exclude flavored e-vapor products. (c) NO scenario: JUUL files flavor PMTAs sometime in 2026-27, the FDA reviews them for a year or more, and nothing reaches the public before the deadline. (d) YES scenario: JUUL quickly files a Mango PMTA for the age-gated JUUL2, citing the Glas mango precedent, and either gets unusually fast authorization or launches under enforcement discretion. Alternatively, a JUUL Mango release abroad counts; JUUL2 Mango already sells in the UK. But the market staying unresolved after the October 2025 UK launch implies a US release is required. Anchor: Kalshi is at 10% (bid 9 / ask 14), and the recent uptick seems speculative rather than news-driven. Polymarket's 44% comes from a near-zero-volume market ($187) and carries little weight. Given no filing and the short window, I shade below the Kalshi mid to about 5%, keeping some mass on wording ambiguity and surprise regulatory action.
Pipeline Timing
Total pipeline time: 82.1s
Per-tool research timings shown in the Research section above.